Compliance, Regulatory Requirements 28 Jan 2025 transmission, tariffs, regulatory compliance, energy, western area power administration, federal energy
Regulatory Compliance, Trade Investigations 28 Jan 2025 international trade, commerce department, regulatory compliance, china, antidumping
Compliance, Regulation 28 Jan 2025 dea, import application, drug enforcement, regulatory compliance, controlled substances

💼Aveva Drug Delivery Systems Seeks Importer Registration for Controlled Substances

Aveva Drug Delivery Systems, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Regulatory Compliance, Business Agreement 28 Jan 2025 postal service, competitive products, public comment, regulatory compliance, business agreements

📬Notice of New Postal Products and Comment Opportunities by PRC

The Commission is noticing a recent Postal Service filing for the Commission's consideration concerning a negotiated service agreement. This notice informs the public of the filing, invites public comment, and takes other administrative steps.

Learn More
Regulatory Changes, Financial Impacts 28 Jan 2025 nasdaq, regulatory compliance, co-location services, financial implications, securities exchange commission
Regulatory Compliance, Trade Regulations 28 Jan 2025 trade, tariffs, regulatory compliance, commerce, china, manufacturing

📊Court Decision Correction on Tapered Roller Bearing Tariffs

On December 31, 2024, the U.S. Department of Commerce (Commerce) published in the Federal Register the amended final results of the 2018-2019 administrative review of the antidumping duty (AD) order on tapered roller bearings and parts from the People's Republic of China (China). This notice incorrectly stated that for the non- selected companies that do not have a superseding cash deposit rate, Commerce will issue revised cash deposit instructions through U.S. Customs and Border Protection (CBP).

Learn More
Regulatory Compliance, Pharmaceuticals 28 Jan 2025 importation, dea, regulatory compliance, controlled substances, vici health sciences, pharmaceuticals

📋DEA Notice

Vici Health Sciences, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Compliance, Infrastructure Development 27 Jan 2025 columbia gas transmission, natural gas act, public participation, regulatory compliance, intervention deadlines, energy sector
Compliance, Regulatory Changes 27 Jan 2025 regulatory compliance, health regulations, nonprescription drugs, drug application, fda

📜FDA Delays Effective Date for Nonprescription Drug Regulation

In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) is delayed until March 21, 2025.

Learn More
Compliance, Regulatory Requirements 27 Jan 2025 regulatory compliance, sam registration, general services administration, business registration, federal contracts

📝Notarized Document Submission Updates for SAM Registration

Under the provisions of the Paperwork Reduction Act, the Regulatory Secretariat Division will be submitting to the Office of Management and Budget (OMB) a request to review and approve a revision to an existing OMB clearance regarding a notarized document submittal for System for Award Management (SAM) Registration.

Learn More